OUR PARTNERS
AJH doesn’t operate in isolation. Our partner network spans four continents and includes some of the most respected names in psychedelic research, clinical treatment, and university-level neuroscience. Every partnership is built around shared commitment to safety, legality, and evidence-based outcomes.
A global network of research institutions, treatment facilities, and advocacy organizations.
Treatment Facilities
World-class facilities operating in legal jurisdictions, delivering medically supervised entheogenic therapy and generating clinical research data. Each partner is selected for medical rigor, legal compliance, and commitment to evidence-based outcomes.
Ambio Life Sciences
Medical-grade research facility offering ibogaine and DMTx protocols alongside psilocybin programs. Enables multi-compound treatment pathways and rigorous data collection across multiple entheogenic compounds.
Beōnd — Mexico
Ibogaine-assisted treatment in a medically supervised clinical setting. Beōnd provides comprehensive medical monitoring throughout treatment, including cardiac screening and 24/7 clinical oversight. Site of AJH's breakthrough UK Rugby concussion cohort.
Clerkenwell Health — London, UK
Europe's first commercial research site specializing in entheogens and advanced mental health technologies. Partner for UK-based clinical trials and future European expansion.
Eleusis
Treatment and research facility expanding AJH's access to additional compounds and clinical settings.
Experience Onward — Oregon, USA
Psilocybin-assisted therapy operating under Oregon's legal framework. Site of AJH's first cohort. Featured on Fox News for pioneering work with psilocybin and traumatic brain injury. Retreat-style setting with integrated clinical data collection.
Ayahuasca Foundation
Traditional ceremony and education. Supporting AJH's connection to Indigenous healing traditions and ceremonial best practices.
Research & Academic Partners
Our research network includes leading universities and specialized institutions across four continents, driving the science behind athlete recovery.
University of British Columbia — Collaborative research partnership in psychedelic neuroscience
Arizona State University — Research collaboration on entheogenic therapy outcomes
Imperial College London — World-leading psychedelic research institution
University of Southampton — Academic research partnership
UCL Genomics — Genomic analysis supporting AJH's biological research
University of Lima — Granted first-of-its-kind ethics approval for AJH's multi-site, multi-compound study
Psychae Institute — Psychedelic research institute
Clerkenwell Health — Europe's pioneering hub for mental health research
Advocacy & Specialized Partners
Organizations advancing research methodology, integration support, and equitable access to entheogenic therapy.
Onaya Science — Independent research organization dedicated to translating Indigenous plant medicine wisdom into scientific methodology. Co-manages AJH's research protocol and data collection framework.
Hystelica — Researching, advocating, and educating for safe and effective entheogenic use for women. Ensuring gender-specific needs are considered in the future of entheogenic therapy.
re:mind — Technology-enabled integration and community support platform. Supports long-term follow-up and peer connection post-treatment.
Heroic Hearts Project — Veterans-focused psychedelic therapy advocacy organization. Shared research experience informing AJH's study design and veteran crossover protocols.
The Psychedelic Experience Clinic — Not-for-profit providing accessible and affordable psychotherapy to individuals following entheogenic experiences. Key integration partner for AJH cohort participants.
INVESTMENT & ADVISORY
Strategic investors and advisors supporting AJH's growth, research infrastructure, and global expansion.
Investment in psychedelic medicine and mental health innovation
Strategic investment and advisory support